Literature DB >> 8213823

Confirmation of chromosome 9p linkage in familial melanoma.

D J Nancarrow1, G J Mann, E A Holland, G J Walker, S C Beaton, M K Walters, C Luxford, J M Palmer, J A Donald, J L Weber.   

Abstract

Malignant melanoma occurs as a familial cancer in 5%-10% of cases where it segregates in a manner consistent with autosomal dominant inheritance. Evidence from cytogenetics, fine-mapping studies of deletions in melanomas, and recent linkage studies supports the location of a human melanoma predisposition gene on the short arm of chromosome 9. We have carried out linkage analysis using the 9p markers IFNA and D9S126 in 26 Australian melanoma kindreds. Multipoint analysis gave a peak lod score of 4.43, 15 cM centromeric to D9S126, although a lod score of 4.13 was also found 15 cM telomeric of IFNA. These data confirm the existence of a melanoma susceptibility gene on 9p and indicate that this locus most probably lies outside of the IFNA-D9S126 interval. No significant heterogeneity was found between families, when either pairwise or multipoint data were analyzed using HOMOG.

Entities:  

Mesh:

Year:  1993        PMID: 8213823      PMCID: PMC1682395     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  22 in total

1.  Dinucleotide repeat polymorphism at the IFNA locus (9p22).

Authors:  D J Kwiatkowski; M O Diaz
Journal:  Hum Mol Genet       Date:  1992-11       Impact factor: 6.150

2.  Locus for susceptibility to melanoma on chromosome 1p.

Authors:  N A Gruis; W Bergman; R R Frants
Journal:  N Engl J Med       Date:  1990-03-22       Impact factor: 91.245

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Exclusion of the dysplastic nevus syndrome (DNS) locus from the short arm of chromosome 1 by linkage studies in Dutch families.

Authors:  A van Haeringen; W Bergman; M R Nelen; E van der Kooij-Meijs; I Hendrikse; J T Wijnen; P M Khan; E C Klasen; R R Frants
Journal:  Genomics       Date:  1989-07       Impact factor: 5.736

5.  Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p.

Authors:  S J Bale; N C Dracopoli; M A Tucker; W H Clark; M C Fraser; B Z Stanger; P Green; H Donis-Keller; D E Housman; M H Greene
Journal:  N Engl J Med       Date:  1989-05-25       Impact factor: 91.245

6.  Chromosome 9p and hereditary cutaneous malignant melanoma.

Authors:  S J Bale; N C Dracopoli
Journal:  J Natl Cancer Inst       Date:  1989-01-04       Impact factor: 13.506

7.  Loss of heterozygosity at autosomal and X-linked loci during tumor progression in a patient with melanoma.

Authors:  N C Dracopoli; B Alhadeff; A N Houghton; L J Old
Journal:  Cancer Res       Date:  1987-08-01       Impact factor: 12.701

8.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Cytogenetic analysis of melanocytes from premalignant nevi and melanomas.

Authors:  J M Cowan; R Halaban; U Francke
Journal:  J Natl Cancer Inst       Date:  1988-09-21       Impact factor: 13.506

10.  Chromosome changes in metastatic human melanoma.

Authors:  J Limon; P Dal Cin; S N Sait; C Karakousis; A A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  1988-02
View more
  13 in total

Review 1.  The CDKN2A (p16) gene and human cancer.

Authors:  W D Foulkes; T Y Flanders; P M Pollock; N K Hayward
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

2.  Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi.

Authors:  A M Goldstein; L R Goldin; N C Dracopoli; W H Clark; M A Tucker
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

Review 3.  Molecular aspects of melanocytic dysplastic nevi.

Authors:  Mahmoud Rezk Abd-Elwahed Hussein; Gary Stewart Wood
Journal:  J Mol Diagn       Date:  2002-05       Impact factor: 5.568

4.  Temperature-sensitive mutants of p16CDKN2 associated with familial melanoma.

Authors:  D Parry; G Peters
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

5.  A population-based study of Australian twins with melanoma suggests a strong genetic contribution to liability.

Authors:  Sri N Shekar; David L Duffy; Philippa Youl; Amanda J Baxter; Marina Kvaskoff; David C Whiteman; Adèle C Green; Maria C Hughes; Nicholas K Hayward; Marylon Coates; Nicholas G Martin
Journal:  J Invest Dermatol       Date:  2009-04-09       Impact factor: 8.551

Review 6.  Familial melanoma: a complex disorder leading to controversy on DNA testing.

Authors:  Femke A de Snoo; Wilma Bergman; Nelleke A Gruis
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

7.  Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas.

Authors:  J Weaver-Feldhaus; N A Gruis; S Neuhausen; D Le Paslier; E Stockert; M H Skolnick; A Kamb
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

Review 8.  Presymptomatic testing for genetic diseases of later life. Pharmacoepidemiological considerations.

Authors:  B J Rossiter; C T Caskey
Journal:  Drugs Aging       Date:  1995-08       Impact factor: 3.923

9.  Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside the p16 (CDKN2) gene.

Authors:  S Puig; A Ruiz; C Lázaro; T Castel; M Lynch; J Palou; A Vilalta; J Weissenbach; J M Mascaro; X Estivill
Journal:  Am J Hum Genet       Date:  1995-08       Impact factor: 11.025

10.  Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity.

Authors:  A M Goldstein; N C Dracopoli; M Engelstein; M C Fraser; W H Clark; M A Tucker
Journal:  Am J Hum Genet       Date:  1994-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.